EWM
TCRT icon

Edge Wealth Management’s Alaunos Therapeutics TCRT Stock Holding History

Edge Wealth Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10
Closed -$7K – 420
2014
Q1 		$7K Hold
10
– – ﹤0.01% 309
2013
Q4 		$7K Hold
10
– – ﹤0.01% 282
2013
Q3 		$6K Hold
10
– – ﹤0.01% 263
2013
Q2 		$3K Buy
+10
New +$2.78K ﹤0.01% 279

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Edge Wealth Management's TCRT Position: Q2 2014 in Review

Edge Wealth Management sold out of Alaunos Therapeutics (TCRT) in Q2 2014, closing a stake of 10 shares — an estimated $7K sold.

Edge Wealth Management first reported a position in TCRT in Q2 2013 and held it in 4 quarters. The position peaked at $7K in Q1 2014. 92 funds tracked by Wall St. Rank hold TCRT as of Q2 2014.

  • Edge Wealth Management reported no remaining Alaunos Therapeutics position as of Q2 2014 after selling out during the quarter.
  • Edge Wealth Management sold 10 Alaunos Therapeutics shares in Q2 2014, an estimated $7K.
  • Edge Wealth Management first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 4 quarters.
  • Edge Wealth Management's Alaunos Therapeutics position peaked at $7K in Q1 2014.
  • 92 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2014.

Based on Edge Wealth Management's 13F filing for Q2 2014, filed 11 Jul 2014.